| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.09 | 0.08 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.095 | 0.09 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |